Skip to main content

Table 1 Selected indicator conditions, associated specialties, and specific selection criteria for eligibility

From: Promoting HIV indicator condition-guided testing in hospital settings (PROTEST 2.0): study protocol for a multicentre interventional study

Indicator condition

Main Specialty

Indicator condition-specific selection criteria

Tuberculosis

Pulmonology

Patients with latent M. tuberculosis infection, but no tuberculosis disease, are excluded

Cervical cancer or CIN 3+

Gynaecology

Patients without biopsy-confirmed high-grade dysplasia (CIN 3+) or carcinoma (invasive or non-invasive) are excluded

Vulvar cancer or VIN 3+

Gynaecology

Patients without biopsy-confirmed high-grade dysplasia (VIN 3+) or carcinoma (invasive or non-invasive) are excluded

Malignant lymphoma

Haematology

All types of malignant lymphoma, including all subtypes of Hodgkin’s lymphoma and non-Hodgkin lymphoma are included

Hepatitis B

Gastroenterology

Both acute and chronic hepatitis B cases are included

Hepatitis C

Gastroenterology

Both acute and chronic hepatitis C cases are included

Peripheral neuropathy

Neurology

Patients with known diabetes mellitus before presenting and patients for whom no diagnostic laboratory workup was indicated are excluded

  1. CIN cervical intraepithelial neoplasia, VIN vulvar intraepithelial neoplasia